Xconomy.com -- San Diego-based Tragara Pharmaceuticals, which has focused its current drug development on two compounds for treating tumors, has raised $5 million of a targeted $10 million venture round, according to a recent regulatory filing. The company raised $40 million in its Series A round in 2007.
